Pazopanib efficacy in renal cell carcinoma: evidence for predictive genetic markers in angiogenesis-related and exposure-related genes. [electronic resource]
Producer: 20110823Description: 2557-64 p. digitalISSN:- 1527-7755
- Angiogenesis Inhibitors -- pharmacology
- Carcinoma, Renal Cell -- drug therapy
- Clinical Trials, Phase II as Topic -- statistics & numerical data
- Cross-Over Studies
- DNA Mutational Analysis
- Disease-Free Survival
- Genetic Markers
- Genotype
- Germ-Line Mutation
- Humans
- Indazoles
- Kidney Neoplasms -- drug therapy
- Multicenter Studies as Topic -- statistics & numerical data
- Neoplasm Proteins -- genetics
- Neovascularization, Physiologic -- genetics
- Polymorphism, Single Nucleotide
- Proportional Hazards Models
- Pyrimidines -- pharmacology
- Randomized Controlled Trials as Topic -- statistics & numerical data
- Receptor Protein-Tyrosine Kinases -- antagonists & inhibitors
- Sulfonamides -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.